about
The gut hormones in appetite regulationTherapeutic potential for novel drugs targeting the type 1 cholecystokinin receptorThe bHLH transcription factor Mist1 is required to maintain exocrine pancreas cell organization and acinar cell identityGastrointestinal hormones regulating appetiteNew perspectives on exploitation of incretin peptides for the treatment of diabetes and related disordersDiet in irritable bowel syndromeBi-directional effect of cholecystokinin receptor-2 overexpression on stress-triggered fear memory and anxiety in the mouseEffects of exogenous cholecystokinin octapeptide on acquisition of naloxone precipitated withdrawal induced conditioned place aversion in ratsIntracellular signal transduction during gastrin-induced histamine secretion in rat gastric ECL cellsCholecystokinin facilitates glutamate release by increasing the number of readily releasable vesicles and releasing probability.Gastrin decreases Na+,K+-ATPase activity via a PI 3-kinase- and PKC-dependent pathway in human renal proximal tubule cells.Cholecystokinin receptors in Atlantic salmon: molecular cloning, gene expression, and structural basis.Gastrin induces sodium-hydrogen exchanger 3 phosphorylation and mTOR activation via a phosphoinositide 3-kinase-/protein kinase C-dependent but AKT-independent pathway in renal proximal tubule cells derived from a normotensive male human.Cholecystokinin receptor subtypes: role in the modulation of anxiety-related and reward-related behaviours in animal models.Enrichment of in vivo transcription data from dietary intervention studies with in vitro data provides improved insight into gene regulation mechanisms in the intestinal mucosa.Gene Expression Profiling during Pregnancy in Rat Brain Tissue.The role of a pre-load beverage on gastric volume and food intake: comparison between non-caloric carbonated and non-carbonated beverage.Acinar cell-specific knockout of the PTHrP gene decreases the proinflammatory and profibrotic responses in pancreatitis.Drug treatment of obesity: from past failures to future successes?Comparative pharmacology of cholecystokinin induced activation of cultured vagal afferent neurons from rats and miceCholecystokinin receptor-1 mediates the inhibitory effects of exogenous cholecystokinin octapeptide on cellular morphine dependenceCholecystokinin: a multi-functional molecular switch of neuronal circuits.Presence of CCK-A, B receptors and effect of gastrin and cholecystokinin on growth of pancreatobiliary cancer cell lines.Role of CCK and potential utility of CCK1 receptor antagonism in the treatment of pancreatitis induced by biliary tract obstruction.Cholecystokinin facilitates neuronal excitability in the entorhinal cortex via activation of TRPC-like channels.Requirement of phospholipase C and protein kinase C in cholecystokinin-mediated facilitation of NMDA channel function and anxiety-like behavior.Peptides and Gd complexes containing colloidal assemblies as tumor-specific contrast agents in MRI: physicochemical characterization.Expression of CCK Receptors in Carcinoma Gallbladder and Cholelithiasis: A Pilot Study.Phospholipase C not protein kinase C is required for the activation of TRPC5 channels by cholecystokininExpression and cell-specific localization of cholecystokinin receptors in rat lung.Cytotoxic agents directed to peptide hormone receptors: defining the requirements for a successful drug.Neural mechanism of gastric motility regulation by electroacupuncture at RN12 and BL21: A paraventricular hypothalamic nucleus-dorsal vagal complex-vagus nerve-gastric channel pathwayControl of gastric acid secretion in somatostatin receptor 2 deficient mice: shift from endocrine/paracrine to neurocrine pathwaysMolecular mechanisms of appetite regulation.Methods to evaluate biliary excretion of drugs in humans: an updated review.Temporal association of elevated cholecystokininergic tone and adolescent trauma is critical for posttraumatic stress disorder-like behavior in adult mice.CCKB/gastrin receptor antagonists: recent advances and potential uses in gastric secretory disordersPKD3 is the predominant protein kinase D isoform in mouse exocrine pancreas and promotes hormone-induced amylase secretionChallenges to the therapeutic pipeline for irritable bowel syndrome: end points and regulatory hurdles.Targeted disruption of the murine cholecystokinin-1 receptor promotes intestinal cholesterol absorption and susceptibility to cholesterol cholelithiasis.
P2860
Q21296779-9A94E2ED-AD71-40E4-A32B-C78CE0E4076CQ24628602-0FE11DEA-4EB3-46DD-B645-CB54427FDD1BQ24653476-92EF9EAF-CD31-4E56-8C23-0E53DDC462BEQ24669951-953813F7-E1E1-4592-913C-F1BBC1B31DF1Q26777654-F05B32BB-284E-413B-A661-A4DCE7277B52Q26824367-0D9D5E41-ABA3-4BD0-A0DF-5BF3D0DEA7EEQ28476669-06E5C855-0B10-48F5-B4A8-7CB7A21B7DF2Q28481612-17E93A8F-F337-4D4A-B88F-40CEA2D4179CQ28570748-31503848-FEE3-4F7C-8ABE-969CE572EE59Q28578004-32DAFFDD-5925-4924-A84D-53A05B644C6EQ30353313-F6AE1355-3A40-4A2A-8105-9B589FC6ABBEQ30356359-2525595E-298E-4F5A-BF4F-F4AB87AB859FQ30414992-D9D96FA2-0D23-4AE0-88FB-814ED3FDA27EQ30532041-3ADA94B0-993A-46E0-9F01-104620F1F14BQ33560794-BA21F955-D3C6-42DC-9D92-A422C3A9580EQ33788918-C52F549D-6DB8-455E-A1C0-10EA4629EFB2Q34048274-34E3DACA-C0A6-4601-9AD4-4E1933D55BF5Q34131104-F3441CB3-7F3B-4090-B912-31D90AF3F1A1Q34135268-5D772C49-6BD1-4D50-BA91-75ADB19236B3Q34238683-FB5B2ACF-FB79-4ED6-A00C-FDB9140B48F7Q34298025-CB69AD43-860F-4B1F-A1A8-ECB15B7A622CQ34420892-B8B981E8-58AF-41AD-8DA7-E4F4EC83291DQ34604661-FDC66FB0-66C2-4B95-B893-070D1896B425Q34754730-7498BCAD-2A50-40B5-AE7A-8BB04CE4CA47Q35217667-E7E394EB-E7BA-4EC9-8539-52BB4F847EBFQ35785604-2AB1B554-0D35-42E8-9E94-0E7FDE1C6384Q35940186-B4529EBE-92CB-4BFD-B848-F029A0521C4BQ36068171-381FD5E9-3247-4B2B-9B53-F1ADE244BFD2Q36110016-65978766-A5E6-4531-8B47-175AE02BB756Q36179833-1982D0EC-3735-449F-814A-92EA4DE22AB6Q36312379-F4CBB880-0E52-461E-A48F-9A20C378FE59Q36401580-16FADAB6-8A5F-4A93-92A5-5CF62AEDA8C5Q36415827-F01A6630-8584-4E46-A98F-3D28E01AFBA3Q36490110-AF47CC22-C2F8-447E-A6FE-D0D6FA0F4FF2Q36495774-12DDF447-54C1-4AC1-AFD6-4B3102A5E7C1Q36782164-FB0744BF-A022-48CA-96E4-AC924E985B18Q36987633-2EDD380B-8139-4724-9255-23B04F508E88Q37068055-B2907793-A680-4A76-A2D1-4F5F85EE447EQ37164063-2717151A-479D-4355-837A-1C682D099753Q37286178-72BC327B-04CD-4FA3-9DB9-7617842AFF07
P2860
description
1995 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 1995
@ast
im November 1995 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1995/11/01)
@sk
vědecký článek publikovaný v roce 1995
@cs
wetenschappelijk artikel (gepubliceerd op 1995/11/01)
@nl
наукова стаття, опублікована в листопаді 1995
@uk
مقالة علمية (نشرت في نوفمبر 1995)
@ar
name
Cholecystokinin receptors
@ast
Cholecystokinin receptors
@en
Cholecystokinin receptors
@nl
type
label
Cholecystokinin receptors
@ast
Cholecystokinin receptors
@en
Cholecystokinin receptors
@nl
prefLabel
Cholecystokinin receptors
@ast
Cholecystokinin receptors
@en
Cholecystokinin receptors
@nl
P1476
Cholecystokinin receptors
@en
P2093
S. A. Wank
P304
P356
10.1152/AJPGI.1995.269.5.G628
P407
P433
P577
1995-11-01T00:00:00Z